NCT04682483 · Tufts Medical Center
Cardiogenic Shock Working Group Registry
(CSWG)
What this study is about
The Cardiogenic Shock Working Group is a conducted at multiple hospitals registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
View original scientific description
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Patients must have cardiogenic shock. Cardiogenic shock is defined by at least one of the two categories below:
- At least 2 of the following concurrently at any point during the index hospitalization:
- Cardiac Index \< 2.2
- PAPI \< 1.0
- Cardiac Power Output ≤ 0.6
- MAP \< 60mmHg or a \>30mmHg drop in MAP from baseline
- SBP \< 90mmHg or a \>30mmHg drop in SBP from baseline
- Pulse \> 100
- Require at least one acute mechanical circulatory support device, vasopressor or inotrope to maintain values above the above target. Post-cardiotomy patients must meet the inclusion criteria 72 hours after their surgery to be included in this registry.
Where
- Weston, Florida
- Chicago, Illinois
- Portland, Maine
- Boston, Massachusetts
- Hackensack, New Jersey
- New York, New York
- Portland, Oregon
- Pittsburgh, Pennsylvania
- Dallas, Texas
- Galveston, Texas
- Houston, Texas
- Falls Church, Virginia
And 1 more location — see the full list below.
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 6, 2025 · Source of record for eligibility and locations